Bliss GVS Pharma Ltd. (BLISSGVS-BE): Bliss GVS Pharma Share Price hits fresh 52-week high at Rs 634

Bliss GVS Pharma Share Price moved to Rs 634 on 01 September 2026 at 3:18 PM IST, up 2.86% from the previous close of Rs 616.4, and printed a fresh 52-week high of Rs 634.65. The company’s market capitalisation stood at Rs 6,238.89 crore. For readers tracking Bliss GVS Pharma Share Price Today, the session confirms a new yearly high in the stock, while Bliss GVS Pharma Stock News around the move is best read as a verified price event rather than a story with a disclosed company-specific catalyst. Univest notes the stock is in focus because the price action itself is the event, and the available data sets the context through valuation, profitability and sector benchmarking.

The stock opened at Rs 620 and traded between Rs 591.65 and Rs 634.65 during the session. The gap between the day’s low and the high shows the full intraday range, while turnover stood at Rs 1.12 crore. Univest’s reading of the data is straightforward: the share has marked a fresh 52-week high, and the next comparison points come from fundamentals, sector multiples and peer positioning.

Bliss GVS Pharma Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 634
Previous Close	Rs 616.4
Today's Move	+Rs 17.6 (+2.86%)
Open	Rs 620
High	Rs 634.65
Low	Rs 591.65
Turnover	Rs 1.12 crore
Market Capitalisation	Rs 6,238.89 crore

Bliss GVS Pharma Ltd. (BLISSGVS-BE) traded at Rs 634 versus the previous close of Rs 616.4, a rise of 2.86%. The stock opened at Rs 620, reached a high of Rs 634.65 and touched a low of Rs 591.65.

Bliss GVS Pharma Share Price Today reflects a day gain of Rs 17.6 after closing at Rs 634 against the previous close of Rs 616.4. The stock opened at Rs 620, dipped to Rs 591.65 and then reached Rs 634.65, which is also the fresh 52-week high. The move places the close close to the session peak, with turnover of Rs 1.12 crore showing the value traded during the day. Because the stock also crossed its prior one-year peak, the breakout percentage versus the previous 52-week high works out to a fresh high day, with the new peak set at Rs 634.65. Univest treats this as an event-led price update: the market has recorded a new yearly high, and the verified figures define the move without adding an unlisted catalyst.

For anyone scanning Bliss GVS Pharma Share Price Live, the day structure shows that the stock recovered from the intraday low and finished near the top of the range. That makes the session relevant for Bliss GVS Pharma Share News and for short-term market watchers looking at the latest price behaviour. Univest sees the key takeaway as the recorded high, not a narrative about why the stock rose beyond the supplied facts.

Bliss GVS Pharma Ltd. (BLISSGVS-BE) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 6,238.89 crore
P/E Ratio	48.1x
P/B Ratio	5.31x
ROE	12.11%
ROCE	17.4%
EPS	Rs 12.81
Book Value Per Share	Rs 116
Dividend Yield	0.24%

Bliss GVS Pharma Ltd. (BLISSGVS-BE) fundamental metrics show P/E 48.1x, P/B 5.31x, ROE 12.11%, ROCE 17.4%. These figures provide context only and are not a buy or sell signal.

Bliss GVS Pharma Ltd. has a market capitalisation of Rs 6238.89 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 48.1x, P/B at 5.31x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.11% and ROCE of 17.4%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 12.81, book value per share of Rs 116, dividend yield of 0.24%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.86x, median ROE of 11.79%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	48.1x
Benchmark Median P/E	30.86x
Benchmark Average P/E	48.02x
Benchmark P/E Range	3.87x to 667.16x
Company P/B Ratio	5.31x
Benchmark Median P/B	2.88x
Company ROE	12.11%
Benchmark Median ROE	11.79%
Company ROCE	17.4%
Benchmark Median ROCE	13.63%
Company Market Capitalisation	Rs 6,238.89 crore
Benchmark Median Market Cap	Rs 679.12 crore

Bliss GVS Pharma Ltd. (BLISSGVS-BE) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a P/E ratio of 48.1x, which is above the benchmark median of 30.86x, a difference of +55.87%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a ROE of 12.11%, which is above the benchmark median of 11.79%, a difference of +2.71%. Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a ROCE of 17.4%, which is above the benchmark median of 13.63%, a difference of +27.66%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Supriya Lifescience Ltd.	SUPRIYA	6,433.8	32.43	5.27	20.74	27.63
Innova Captab Ltd.	INNOVACAP	6,036.37	39.47	5.44	13.75	15.04
Orchid Pharma Ltd.	ORCHPHARMA	5,827.43	667.16	4.45	7.86	8.05
Morepen Laboratories Ltd.	MOREPENLAB	5,819.82	41.76	4.51	11.78	15.48
IOL Chemicals And Pharmaceuticals Ltd.	IOLCP	5,717.92	33.84	3.05	7.9	10.65

Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a P/E ratio of 48.1x compared with the displayed peer median of 39.47x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.11% compares with a peer median of 11.78% across the companies shown in the table. ROCE stood at 17.4% versus the displayed peer median of 15.04%, providing a capital-efficiency comparison. Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a market capitalisation of Rs 6,238.89 crore. Among the 5 peers shown, 1 has a larger market capitalisation.

Why Investors Are Watching Bliss GVS Pharma

• Bliss GVS Pharma Share Price touched a fresh 52-week high of Rs 634.65 during the session.
• The stock closed at Rs 634, up Rs 17.6 or 2.86% from the previous close of Rs 616.4.
• Market capitalisation stood at Rs 6,238.89 crore.
• P/E was 48.1, P/B was 5.31, ROE was 12.11% and ROCE was 17.4%.
• Revenue for Jun 2026 was Rs 2,855.76 crore and net profit was Rs 500.97 crore.

About Bliss GVS Pharma

Bliss GVS Pharma Ltd. is classified in Healthcare and the Pharmaceuticals & Drugs industry. The supplied data places the company within a same-industry benchmark set of 199 companies. In the context of Bliss GVS Pharma Share Price and Bliss GVS Pharma Stock News, this classification is useful because it frames the stock against sector valuation, profitability and capital-efficiency data rather than against general market commentary.

Univest uses this company context to help readers connect the latest yearly high with the available financial and comparative metrics. For Bliss GVS Pharma Share Price Today, the company profile is simple and factual: listed on NSE and BSE, operating within pharmaceuticals, and now trading at a fresh 52-week peak.

Track Bliss GVS Pharma Share Price on Univest

Use Bliss GVS Pharma Ltd. (BLISSGVS-BE) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Track Bliss GVS Pharma Share Price on Univest for live share price updates, 52-week levels, valuation ratios, fundamental analysis, peer comparison and shareholding context. Univest also presents the stock in a format designed for quick reading of market cap, company financials and listed-market context.

Frequently Asked Questions

What is Bliss GVS Pharma Share Price today?

Ans. Bliss GVS Pharma Share Price closed at Rs 634, up 2.86% from the previous close of Rs 616.4. The session also recorded a fresh 52-week high of Rs 634.65, keeping the stock in focus for market watchers.

Did Bliss GVS Pharma hit a fresh 52-week high?

Ans. Yes. Bliss GVS Pharma reached Rs 634.65 during the session, which is its fresh 52-week high. The close at Rs 634 shows the stock ended very near that peak, making the event central to today’s stock news.

What was the day’s price move in Bliss GVS Pharma Share Price?

Ans. The share price rose Rs 17.6, or 2.86%, from Rs 616.4 to Rs 634. The stock opened at Rs 620 and traded between Rs 591.65 and Rs 634.65, showing a wide intraday range.

How is Bliss GVS Pharma valued on earnings and book value?

Ans. Bliss GVS Pharma trades at a P/E of 48.1 and a P/B of 5.31. EPS is Rs 12.81 and book value is Rs 116, so the valuation sits above the industry median on both multiples.

What do ROE and ROCE show for Bliss GVS Pharma?

Ans. ROE stands at 12.11% and ROCE at 17.4%. Both are above the same-industry median levels supplied in the benchmark, which gives the latest Bliss GVS Pharma Share Price move useful fundamental context.

How does Bliss GVS Pharma compare with pharmaceutical peers?

Ans. Bliss GVS Pharma’s P/E of 48.1 is above several peers such as Supriya Lifescience and IOL Chemicals, while ROCE of 17.4% is below Supriya Lifescience but above Innova Captab and IOL Chemicals.

What is the market capitalisation of Bliss GVS Pharma?

Ans. Bliss GVS Pharma’s market capitalisation is Rs 6,238.89 crore. That figure places the company close to several listed pharma peers in the benchmark set and helps frame the current Bliss GVS Pharma Share Price.

What revenue and profit figures are available for Bliss GVS Pharma?

Ans. Revenue for Jun 2026 was Rs 2,855.76 crore and net profit was Rs 500.97 crore. Compared with Jun 2025, both figures were higher, which adds financial context to the latest stock move.